In Re: Medical Properties Trust, Inc. Securities Litigation

Background

Christopher Armstrong filed a proposed securities-fraud class action against Medical Properties Trust, Inc. (MPW), Edward K. Aldag, Jr., R. Steven Hamner, and J. Kevin Hanna. The complaint alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Securities and Exchange Commission Rule 10b-5. According to the complaint, the defendants misled investors about MPW’s recapitalization transaction with Prospect Medical Holdings, Inc. The complaint alleges that MPW did not disclose that a California regulatory agency had to approve the transaction and later understated the effect of the agency’s order placing the transaction on hold.

The opinion states that these facts were recited for background and were not findings of fact.

Motion to Appoint Lead Plaintiff

John Cuomo filed an unopposed motion under the Private Securities Litigation Reform Act of 1995 (PSLRA) to be appointed lead plaintiff and to have Pomerantz LLP approved as lead counsel. The PSLRA generally directs the court to select the class member with the largest financial interest who also meets the requirements for adequately representing the class. The statute requires notice of the lawsuit and gives other class members 60 days to seek appointment.

The court found that the required notice was timely published on the day the complaint was filed and corrected four days later. The notice informed investors about the lawsuit, the class period, and the deadline to seek appointment. Cuomo filed his motion by the November 28, 2023 deadline. No competing motion was filed, and the defendants did not oppose Cuomo’s request.

Cuomo claimed a financial loss of $182,229 from transactions in MPW securities. Because no other investor sought appointment and no party challenged Cuomo’s asserted financial interest, the court found that he satisfied the financial-interest requirement.

Rule 23 Requirements

Rule 23 is the federal rule governing class actions. For purposes of selecting a lead plaintiff, the court focused on typicality and adequacy. Typicality asks whether the proposed lead plaintiff’s claims arise from the same conduct and injuries as the other class members’ claims. Adequacy asks whether the proposed lead plaintiff can fairly protect the class’s interests.

The court found that Cuomo met both requirements because he purchased MPW common stock between May 23, 2023, and August 17, 2023, and therefore asserted claims arising from the same alleged conduct as the other investors. The court also considered his substantial financial losses and approximately five years of investing experience. No other movant offered evidence that Cuomo could not adequately represent the class or that he faced defenses unique to him.

Lead Counsel

The PSLRA allows the lead plaintiff, subject to court approval, to select counsel for the class. Cuomo selected Pomerantz LLP. After reviewing Cuomo’s filings and the firm’s résumé, the court found that Pomerantz had substantial securities-litigation experience and could adequately and effectively represent the class.

Disposition

The court held that Cuomo was the presumptive lead plaintiff and that no other movant had rebutted that presumption. It granted Cuomo’s motion for appointment as lead plaintiff and approval of Pomerantz LLP as lead counsel. The Clerk was directed to terminate the pending motion at Doc. 15, and the parties were ordered to file a proposed schedule for any answer or responsive motion within seven days. The opinion did not decide the underlying allegations of securities fraud.